Krystal Biotech, Inc.KRYSNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
43.13%
↑ 123% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-190.95%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 43.13% | +14.0% |
| 2024 | 37.83% | +121.0% |
| 2023 | -180.11% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | +100.0% |
| 2018 | -1046.54% | - |